tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

DarioHealth Announces 20-to-1 Reverse Stock Split

Story Highlights
  • DarioHealth announced a 20-to-1 reverse stock split effective August 28, 2025.
  • The reverse split consolidates shares without affecting stockholder rights or authorized shares.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
DarioHealth Announces 20-to-1 Reverse Stock Split

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

DarioHealth ( (DRIO) ) just unveiled an update.

On August 25, 2025, DarioHealth Corp. announced a 20-to-1 reverse stock split of its common stock, which will take effect on August 28, 2025. This move, approved by the board and stockholders, reduces the number of outstanding shares significantly while maintaining the same authorized shares and stockholder voting power. The reverse split aims to consolidate shares without affecting the proportional rights of stockholders, and it reflects the company’s strategic financial adjustments in the digital health market.

The most recent analyst rating on (DRIO) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on DarioHealth stock, see the DRIO Stock Forecast page.

Spark’s Take on DRIO Stock

According to Spark, TipRanks’ AI Analyst, DRIO is a Neutral.

DarioHealth’s overall stock score is primarily impacted by its financial challenges, including ongoing losses and high leverage. While technical indicators suggest a bearish trend, the company’s strategic initiatives and leadership changes provide some optimism for future growth.

To see Spark’s full report on DRIO stock, click here.

More about DarioHealth

DarioHealth Corp. is a leading digital health company that provides a user-centric, multi-chronic condition digital therapeutics platform. The platform offers personalized interventions for managing chronic conditions such as diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. DarioHealth’s solutions are designed to disrupt traditional healthcare approaches by offering continuous and customized care, aiming to empower users for sustainable behavior change. The company serves health plans, self-insured employers, care providers, and consumers globally.

Average Trading Volume: 180,212

Technical Sentiment Signal: Strong Sell

Current Market Cap: $25.94M

Learn more about DRIO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1